AYM Syntex Limited Reports Complete Fund Utilization with No Deviations for Q3 FY26
AYM Syntex Limited has reported complete utilization of Rs. 141.76 crore raised through preferential issue on October 29, 2024, with no deviations for Q3 FY26. The funds were fully deployed across debt repayment (Rs. 24.00 crore), working capital reduction (Rs. 25.00 crore), general corporate purposes (Rs. 33.76 crore), and capital expenditure (Rs. 59.00 crore). The Audit Committee reviewed the statement on February 13, 2026, with CARE Ratings Limited serving as monitoring agency.

*this image is generated using AI for illustrative purposes only.
AYM Syntex Limited has submitted its quarterly compliance report to BSE and NSE, confirming complete utilization of funds raised through preferential issue without any deviations for the quarter ended December 31, 2025. The textile company filed the mandatory statement under Regulation 32 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Fund Raising Details
The company had raised Rs. 141.76 crore through preferential issue of equity shares on October 29, 2024. CARE Ratings Limited serves as the monitoring agency for the fund utilization, ensuring compliance with the stated objectives and regulatory requirements.
| Parameter | Details |
|---|---|
| Mode of Fund Raising | Preferential issue of Equity Shares |
| Date of Raising Funds | October 29, 2024 |
| Amount Raised | Rs. 141.76 crore |
| Monitoring Agency | CARE Ratings Limited |
| Deviation Status | No |
Fund Utilization Breakdown
The company has fully utilized the raised funds across four designated categories as originally planned. The complete deployment of funds demonstrates effective capital allocation and adherence to the stated objectives outlined during the fund raising process.
| Purpose | Original Allocation (Rs. Crore) | Funds Utilized (Rs. Crore) | Deviation |
|---|---|---|---|
| Repayment of Debt | 24.00 | 24.00 | - |
| Working Capital Reduction | 25.00 | 25.00 | - |
| General Corporate Purposes | 33.76 | 33.76 | - |
| Capital Expenditure | 59.00 | 59.00 | - |
| Total | 141.76 | 141.76 | - |
Regulatory Compliance
The statement was duly reviewed by the company's Audit Committee at its meeting held on February 13, 2026. Both the Audit Committee and auditors provided no adverse comments on the fund utilization, indicating proper deployment of the raised capital.
Key compliance highlights include:
- No deviation in objects or purposes for fund utilization
- Complete utilization of allocated amounts as originally disclosed
- No changes in terms of contracts from the fund raising document
- Timely filing of quarterly compliance report
Corporate Governance
The filing was signed by Company Secretary and Compliance Officer Kaushal Patvi and Chief Financial Officer Abhishek Patwa, demonstrating proper corporate governance practices. The company's adherence to regulatory timelines and complete fund deployment reflects strong financial discipline and management execution capabilities.
Historical Stock Returns for AYM Syntex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.72% | +2.34% | +12.95% | -9.06% | -14.84% | +258.36% |


































